Dynamic Technology Lab’s Inovio Pharmaceuticals INO Stock Holding History

Dynamic Technology Lab’s Portfolio INO Stock Details INO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-2,700	Closed	-$26K	–	1190
2023 Q1	$26K	Buy	+2,700	New	+$46K	﹤0.01%	1016
2022 Q1	–	Sell	-2,893	Closed	-$173K	–	1279
2021 Q4	$173K	Buy	+2,893	New	+$232K	0.02%	985
2017 Q3	–	Sell	-2,101	Closed	-$197K	–	1205
2017 Q2	$197K	Buy	+2,101	New	+$180K	0.04%	885
2016 Q1	–	Sell	-2,198	Closed	-$171K	–	1042
2015 Q4	$171K	Buy	2,198 +750	+52%	+$59.7K	0.05%	739
2015 Q3	$100K	Buy	+1,448	New	+$126K	0.03%	743

Other funds holding INO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Dynamic Technology Lab's INO Position: Q2 2023 in Review

Dynamic Technology Lab sold out of Inovio Pharmaceuticals (INO) in Q2 2023, closing a stake of 2,700 shares — an estimated $26K sold.

Dynamic Technology Lab first reported a position in INO in Q3 2015 and held it in 5 quarters. The position peaked at $197K in Q2 2017. 133 funds tracked by Wall St. Rank hold INO as of Q2 2023.

Dynamic Technology Lab reported no remaining Inovio Pharmaceuticals position as of Q2 2023 after selling out during the quarter.
Dynamic Technology Lab sold 2,700 Inovio Pharmaceuticals shares in Q2 2023, an estimated $26K.
Dynamic Technology Lab first reported a position in Inovio Pharmaceuticals in Q3 2015 and held it in 5 quarters.
Dynamic Technology Lab's Inovio Pharmaceuticals position peaked at $197K in Q2 2017.
133 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q2 2023.

Based on Dynamic Technology Lab's 13F filing for Q2 2023, filed 14 Aug 2023.